Business partnership contract is executed with ClinActis, CRO in Singapore.

Novumella Inc. signed a MSA with ClinActis Pte Ltd, Singapore headquartered contract clinical research organization (CRO) today.

ClinActis is a CRO that has conducted clinical trials in Asia Pacific from Western and Asian pharmaceutical companies for 9 years.

ClinActis has decided to collaborate with Novumcella to cover clinical trials in Japan.

Novumcella is a research and development venture for products such as regenerative medicine. We have conducted regulatory consultation and medical big data analysis as CRO projects.

Novumcella is pleased to announce that we collaborate with ClinActis by working partnership with Japanese CROs.